Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOCUS ADHD App for Adult ADHD Monitoring
NCT05551689Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- May 2021
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Randomised, single-blind trial in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoints: Adherence to pharmacological treatment of ADHD at 12 weeks and Change in ADHD Knowledge at 12 weeks. Started May 2021; status: completed.
02
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT05551689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05551689.